Back to Research Hub
AbCellera Biologics Inc.
ABCL
$11.53+0.17 (+1.50%)
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs.
StreetsValue research for AbCellera Biologics Inc. (ABCL)
Members get the full report for AbCellera Biologics Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.